Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Molecular Pharmaceutics
|
October 1, 2011
Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma
Ariosto S Silva, Robert A Gatenby
Biology Direct
|
April 22, 2010
A theoretical quantitative model for evolution of cancer chemotherapy resistance
Ariosto S Silva, Robert A Gatenby
Cancer Research
|
March 12, 2009
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion
Ariosto S Silva, Jose A Yunes, Robert J Gillies, et al.
Trends in Cancer
|
March 7, 2018
Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All
Bijal Shah, Xiaohong Zhao, Ariosto S Silva, et al.
Journal of Theoretical Biology
|
November 6, 2009
A quantitative theoretical model for the development of malignancy in ductal carcinoma in situ
Ariosto S Silva, Robert A Gatenby, Robert J Gillies, et al.
Cancer Research
|
June 3, 2009
Adaptive therapy
Robert A Gatenby, Ariosto S Silva, Robert J Gillies, et al.
Cancer Research
|
October 16, 2012
Evolutionary approaches to prolong progression-free survival in breast cancer
Ariosto S Silva, Yoonseok Kam, Zayar P Khin, et al.
Hemasphere
|
January 12, 2026
Navigating the evolving management of smoldering multiple myeloma
M Bakri Hammami, Rafael R Canevarolo, Ariosto S Silva, et al.
Cancer Research
|
August 24, 2011
Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model
Hyung-Ok Lee, Ariosto S Silva, Susanna Concilio, et al.
Cancer Research
|
December 7, 2013
A preclinical assay for chemosensitivity in multiple myeloma
Zayar P Khin, Maria L C Ribeiro, Timothy Jacobson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Molecular Pharmaceutics
|
October 1, 2011
Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma
Ariosto S Silva, Robert A Gatenby
Biology Direct
|
April 22, 2010
A theoretical quantitative model for evolution of cancer chemotherapy resistance
Ariosto S Silva, Robert A Gatenby
Cancer Research
|
March 12, 2009
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion
Ariosto S Silva, Jose A Yunes, Robert J Gillies, et al.
Trends in Cancer
|
March 7, 2018
Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All
Bijal Shah, Xiaohong Zhao, Ariosto S Silva, et al.
Journal of Theoretical Biology
|
November 6, 2009
A quantitative theoretical model for the development of malignancy in ductal carcinoma in situ
Ariosto S Silva, Robert A Gatenby, Robert J Gillies, et al.
Cancer Research
|
June 3, 2009
Adaptive therapy
Robert A Gatenby, Ariosto S Silva, Robert J Gillies, et al.
Cancer Research
|
October 16, 2012
Evolutionary approaches to prolong progression-free survival in breast cancer
Ariosto S Silva, Yoonseok Kam, Zayar P Khin, et al.
Hemasphere
|
January 12, 2026
Navigating the evolving management of smoldering multiple myeloma
M Bakri Hammami, Rafael R Canevarolo, Ariosto S Silva, et al.
Cancer Research
|
August 24, 2011
Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model
Hyung-Ok Lee, Ariosto S Silva, Susanna Concilio, et al.
Cancer Research
|
December 7, 2013
A preclinical assay for chemosensitivity in multiple myeloma
Zayar P Khin, Maria L C Ribeiro, Timothy Jacobson, et al.
Page
of 4